Concepedia

Cytogenetic Relapse

Cytogenetic Relapse is a type of disease recurrence characterized by the reappearance of abnormal chromosomal patterns in hematopoietic cells, detectable by cytogenetic analysis, following a period of remission in malignancies such as leukemia.

479

Publications

35.5K

Citations

3.4K

Authors

938

Institutions

Publications per year

2017–2026

56

Parents

Publications

479

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

Hagop Kantarjian, Charles L. Sawyers, Andreas Hochhaus et al. · New England Journal of Medicine · 2002 · 2K citations · Full text

, , +14

Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias

Moshe Talpaz, Neil P. Shah, Hagop M. Kantarjian et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

, , +15

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

John C. Byrd · Blood · 2002 · 1.6K citations

, , +16

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

Moshe Talpaz · Blood · 2002 · 1K citations

, , +12

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

Adele K. Fielding, Susan Richards, Rajesh Chopra et al. · Blood · 2006 · 843 citations · Full text

, , +9

1–5 of 479

Authors

3.4K

  1. HM
    Hagop M. Kantarjian

    The University of Texas MD Anderson Cancer Center, United States

    25 publications · 5.1K citations

    21

    h-index

  2. JE
    Jörge E. Cortes

    The University of Texas MD Anderson Cancer Center, United States

    14 publications · 2.8K citations

    14

    h-index

  3. MT
    Moshe Talpaz

    The University of Texas MD Anderson Cancer Center, United States

    12 publications · 5.9K citations

    12

    h-index

  4. AH
    Andreas Hochhaus

    Jena University Hospital, Germany

    12 publications · 3.9K citations

    11

    h-index

  5. MB
    Michele Baccarani

    University of Bologna, Italy

    10 publications · 1.9K citations

    10

    h-index

1–5 of 3.4K

Institutions

938

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    31 h-index

    272 publications

    34.8K citations

  2. Heidelberg University

    Heidelberg, Germany

    16 h-index

    88 publications

    10.9K citations

  3. University of Chicago

    Chicago, United States

    14 h-index

    82 publications

    5.6K citations

  4. Hammersmith Hospital

    London, United Kingdom

    13 h-index

    77 publications

    8.9K citations

  5. Dana-Farber Cancer Institute

    Boston, United States

    12 h-index

    32 publications

    2.9K citations

  6. Inserm

    Paris, France

    12 h-index

    57 publications

    4.2K citations

  7. Charité - Universitätsmedizin Berlin

    Berlin, Germany

    11 h-index

    44 publications

    1.7K citations

  8. Sapienza University of Rome

    Rome, Italy

    11 h-index

    55 publications

    2.4K citations

1–8 of 938

Venues

  1. Blood

    83 publications · 13.1K citations

    54

    h-index

  2. British Journal of Haematology

    BJH · 50 publications · 2.9K citations

    30

    h-index

  3. Leukemia

    25 publications · 2.5K citations

    23

    h-index

  4. PubMed

    Repository · 39 publications · 1.2K citations

    22

    h-index

  5. Journal of Clinical Oncology

    18 publications · 2.2K citations

    17

    h-index

1–5